Search Results
Data Demonstrate Efficacy of 3 PARP Inhibitors in Ovarian Cancer
Case 3: Benefit of PARP Inhibitor Maintenance in Ovarian Cancer
Clinical Data with PARP Inhibitors in Ovarian Cancer
PARP inhibitors in ovarian cancer: Clinical updates from SGO 2023
The Therapeutic Potential of Novel PARP Inhibitors in the Clinic for Epithelial Ovarian Cancer
PARP Inhibitors for Ovarian Cancer: Use of Olaparib
PARP inhibitors as first-line maintenance therapy in ovarian cancer
The potential of PARP inhibitors in ovarian cancer: PAOLA-1, PRIMA & VELIA
Cases from the Community: Integrating New Research Findings into Current Practice — Gynecologic C...
Ongoing Clinical Trials with PARP Inhibitors in Ovarian Cancer
Personalizing Advanced Ovarian Cancer Treatment With PARP Inhibitors and Novel Approaches
WATCH NOW - Appraising Current Safety and Efficacy Data for PARP Inhibitors in Ovarian Cancer
